(Q37132190)

18 August 2017

1 reference

title

Augmentation strategies in the treatment of major depressive disorder. Recent findings and current status of augmentation strategies (English)

1 reference

18 August 2017

J Craig Nelson

1

1 reference

PubMed ID

18396508

18 August 2017

language of work or name

1 reference

1 December 2007

1 reference

18 August 2017

1 reference

18 August 2017

12

1 reference

18 August 2017

12 Suppl 22

1 reference

18 August 2017

6-9

1 reference

Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study.

18 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Testosterone replacement therapy for hypogonadal men with SSRI-refractory depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

A Double-Blind, Randomized, Placebo-Controlled Trial of Augmentation With Lamotrigine or Placebo in Patients Concomitantly Treated With Fluoxetine for Resistant Major Depressive Episodes

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Lamotrigine as an augmentation agent in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Lamotrigine augmentation strategy for patients with treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Failure of T3 to potentiate tricyclic antidepressant response

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Lamotrigine adjunctive treatment in resistant unipolar depression: an open, descriptive study.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Lithium Augmentation of Nortriptyline for Subjects Resistant to Multiple Antidepressants

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Intramuscular testosterone supplementation to selective serotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Lithium augmentation in psychotic depression refractory to combined drug treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Fluoxetine potentiation by buspirone: three case histories

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900016011

7 January 2021

10.1017/S1092852900016011

Identifiers

DOI

0 references

PubMed ID

18396508

1 reference

PubMed ID

18396508